Details for New Drug Application (NDA): 074731
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 074731 describes MINOXIDIL (FOR WOMEN), which is a drug marketed by P And L, Taro, Akorn, Apotex Inc, L Perrigo Co, and Sight Pharms, and is included in six NDAs. It is available from twenty-nine suppliers. Additional details are available on the MINOXIDIL (FOR WOMEN) profile page.
The generic ingredient in MINOXIDIL (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
The generic ingredient in MINOXIDIL (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 074731
| Tradename: | MINOXIDIL (FOR WOMEN) |
| Applicant: | Akorn |
| Ingredient: | minoxidil |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 074731
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
| Approval Date: | Dec 24, 1996 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
| Approval Date: | May 11, 2005 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
